Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.02 EUR | -0.57% | +0.64% | +22.93% |
05-29 | Sales in Milan; but Philogen is at annual peak | AN |
05-29 | Milan opens in red; new grits for MPS | AN |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+22.93% | 3.48B | - | ||
+17.08% | 572B | C+ | ||
+17.85% | 310B | C+ | ||
+15.45% | 253B | C+ | ||
+19.26% | 205B | C | ||
+20.43% | 182B | B- | ||
+25.50% | 169B | B- | ||
+7.49% | 163B | C+ | ||
+9.66% | 152B | B- | ||
-9.56% | 135B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BPSO Stock
- 593 Stock
- Ratings Banca Popolare di Sondrio S.p.A